In animal studies, BPC-157 increased blood vessel growth and helped restore blood flow to injured tissue, which may support faster recovery in tendons, muscles, and ligaments
Patients may experience hallucinations, delusions, disorganized thinking, social withdrawal, emotional dullness, and cognitive difficulties
Thursdays regulatory victory is backed by data from the Phase IIb HERIZON-BTC-01 study, which reported a 41.3% confirmed objective response rate in patients treated with Ziihera, with treatment response lasting for a median of 12.9 months
Cagrilintide is studied in vitro for its affinity across the amylin receptor family (AMY1R, AMY2R, AMY3R) and its calcitonin-receptor cross-reactivity